CompletedNCT00141505
Effect of bifeprunox on valproate levels in bipolar I
About this title
Read the official source — NCT00141505This study evaluated the safety of Bifeprunox for people with bipolarity.
Medication studyAges 18–65United States
Understand this study
What did researchers investigate?
This study evaluated the safety of Bifeprunox for people with bipolarity.
Who was this study for?
This study was for people with type I bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- AtlantaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateFebruary 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Solvay Pharmaceuticals
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00141505
- Official title
Show the full official title
Placebo-controlled Study on the Pharmacokinetics,Pharmacodynamics, Safety and Tolerability of Concurrent Valproate and Bifeprunox Administration in Subjects With Bipolar I Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Atlanta
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the safety of Bifeprunox for people with bipolarity.
Who is behind this study?
The study sponsor is Solvay Pharmaceuticals.
Did this study involve medication?
Yes. The study involved medication, including Bifeprunox.
Who was this study for?
This study was for people with type I bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
